Compare Abeona Therapeutics Inc (ABEO) vs Bitwise Crypto Industry Innovators ETF (BITQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Bitwise Crypto Industry Innovators ETF — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Bitwise Crypto Industry Innovators ETF trades at $23.42. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Bitwise Crypto Industry Innovators ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | BITQ | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Crypto-linked |
52-Week High | $7.23 | $30.43 |
52-Week Low | $4.17 | $16.74 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
BITQ trades at $24.83, up 4.37% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. Support is firm near $24, while resistance sits at $25-$26. The ETF's performance remains tied to crypto industry sentiment, with recent news highlighting investor outflows from Bitcoin ETFs amid market volatility. Financial ratios are unavailable, limiting fundamental clarity.
Outlook is cautious due to bearish technicals and sector headwinds. Opportunities exist if crypto markets rebound, but risks include regulatory uncertainty and reliance on volatile underlying assets. Investors should monitor ETF inflows and broader crypto adoption trends for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Bitwise Crypto Industry Innovators ETF
BITQ tracks companies at the forefront of the crypto economy, including miners, equipment suppliers, and financial service providers. It offers indirect exposure to the growth of the broader crypto ecosystem.
Read more on BITQ →
